Literature DB >> 25965729

CRISPR germline editing reverberates through biotech industry.

Cormac Sheridan.   

Abstract

Mesh：

Year:  2015        PMID： 25965729     DOI： 10.1038/nbt0515-431

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Don't edit the human germ line.

Authors:  Edward Lanphier; Fyodor Urnov; Sarah Ehlen Haecker; Michael Werner; Joanna Smolenski
Journal:  Nature       Date:  2015-03-26       Impact factor: 49.962

Review 2.  Purification of oogonial stem cells from adult mouse and human ovaries: an assessment of the literature and a view toward the future.

Authors:  Dori C Woods; Yvonne A R White; Jonathan L Tilly
Journal:  Reprod Sci       Date:  2012-09-27       Impact factor: 3.060

3.  Germline stem cells and follicular renewal in the postnatal mammalian ovary.

Authors:  Joshua Johnson; Jacqueline Canning; Tomoko Kaneko; James K Pru; Jonathan L Tilly
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

4.  Biotechnology. A prudent path forward for genomic engineering and germline gene modification.

Authors:  David Baltimore; Paul Berg; Michael Botchan; Dana Carroll; R Alta Charo; George Church; Jacob E Corn; George Q Daley; Jennifer A Doudna; Marsha Fenner; Henry T Greely; Martin Jinek; G Steven Martin; Edward Penhoet; Jennifer Puck; Samuel H Sternberg; Jonathan S Weissman; Keith R Yamamoto
Journal:  Science       Date:  2015-03-19       Impact factor: 47.728
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.